{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:02:11Z","timestamp":1789578131605,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02219-1","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:06:21Z","timestamp":1789574781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chitosan\u2013TPP modification of SNEDDS enhances mucin interaction, apparent epithelial transport, and oral exposure of ezetimibe"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6813-0539","authenticated-orcid":false,"given":"Ju Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1861-2302","authenticated-orcid":false,"given":"Ji Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-2531","authenticated-orcid":false,"given":"Jung Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2219_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/pharmaceutics15020484","volume":"15","author":"J Lou","year":"2023","unstructured":"Lou J, Duan H, Qin Q, Teng Z, Gan F, Zhou X, et al. Advances in oral drug delivery systems: challenges and opportunities. Pharmaceutics. 2023;15:484.","journal-title":"Pharmaceutics"},{"key":"2219_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/ph15080975","volume":"15","author":"M Azman","year":"2022","unstructured":"Azman M, Sabir AH, Anjani QK, Mustafa MF, Hamid KA. Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery. Pharmaceuticals (Basel). 2022;15:975.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2219_CR3","first-page":"1099","volume":"13","author":"L Kumari","year":"2023","unstructured":"Kumari L, Choudhari Y, Patel P, Gupta GD, Singh D, Rosenholm JM, et al. Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs. Life (Basel). 2023;13:1099.","journal-title":"Life (Basel)"},{"key":"2219_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4274\/tjps.galenos.2021.73554","volume":"19","author":"R Samineni","year":"2022","unstructured":"Samineni R, Chimakurthy J, Konidala S. Emerging role of biopharmaceutical classification and biopharmaceutical drug disposition system in dosage form development: a systematic review. Turk J Pharm Sci. 2022;19:706\u201313.","journal-title":"Turk J Pharm Sci"},{"key":"2219_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1208\/s12249-025-03093-9","volume":"26","author":"SVA Shriyav","year":"2025","unstructured":"Shriyav SVA, Nayak UY, Sathyaranayana MB, Chaudhari BB, Bhat K. Formulation strategy of BCS-II drugs by coupling mechanistic in vitro and nonclinical in vivo data with PBPK: fundamentals of absorption\u2013dissolution to parameterization of modelling and simulation. AAPS PharmSciTech. 2025;26:106.","journal-title":"AAPS PharmSciTech"},{"key":"2219_CR6","first-page":"153","volume":"84","author":"PSV Premakumar","year":"2024","unstructured":"Premakumar PSV, Vishwanath BA, Swapna D. Enhancement of solubility and dissolution rate of BCS class II drugs. Int J Pharm Sci Rev Res. 2024;84:153\u201361.","journal-title":"Int J Pharm Sci Rev Res"},{"key":"2219_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1208\/s12249-025-03287-1","volume":"27","author":"AFP Palacios","year":"2026","unstructured":"Palacios AFP, Parra JAM, Velasco DSC, Rubio DC, Alves IA, Novoa DMA. New strategies to improve drug solubility and its impact on bioavailability: a patent review (2015\u20132024). AAPS PharmSciTech. 2026;27:57.","journal-title":"AAPS PharmSciTech"},{"key":"2219_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.11.036","author":"S Onoue","year":"2025","unstructured":"Onoue S, Yamada K, Sato H. Advanced oral drug delivery systems: current challenges and emerging technologies. Acta Pharm Sin B. 2025. https:\/\/doi.org\/10.1016\/j.apsb.2025.11.036.","journal-title":"Acta Pharm Sin B"},{"key":"2219_CR9","doi-asserted-by":"publisher","first-page":"eabb1989","DOI":"10.1126\/sciadv.abb1989","volume":"6","author":"CS Huang","year":"2020","unstructured":"Huang CS, Yu X, Fordstrom P, Choi K, Chung BC, Roh SH, et al. Cryo-EM structures of NPC1L1 reveal mechanisms of cholesterol transport and ezetimibe inhibition. Sci Adv. 2020;6:eabb1989.","journal-title":"Sci Adv"},{"key":"2219_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s43044-024-00562-7","volume":"76","author":"HSED Taha","year":"2024","unstructured":"Taha HSED, Kandil H, Badran HM, Farag N, Khamis H, Nasr G, et al. 2024 Egyptian consensus statement on the role of non-statin therapies for LDL cholesterol lowering in different patient risk categories. Egypt Heart J. 2024;76:131.","journal-title":"Egypt Heart J"},{"key":"2219_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/10837450.2025.2471461","volume":"30","author":"RBS Darweesh","year":"2025","unstructured":"Darweesh RBS, Al-Qawasmi FS, Khanfar MS. Ezetimibe oral solid lipid nanoparticle by effervescent dispersion method: in vitro characterization and in vivo pharmacokinetic study in rats. Pharm Dev Technol. 2025;30:268\u201379.","journal-title":"Pharm Dev Technol"},{"key":"2219_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12247-024-09911-0","volume":"20","author":"D Elkhayat","year":"2025","unstructured":"Elkhayat D, Abdelmalak NS, Amer R, Awad HH. Ezetimibe loaded nanostructured lipid carriers tablets: response surface methodology, in vitro characterization, and pharmacokinetics study in rats. J Pharm Innov. 2025;20:11.","journal-title":"J Pharm Innov"},{"key":"2219_CR13","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.3390\/pharmaceutics14122743","volume":"14","author":"N Xie","year":"2022","unstructured":"Xie N, Wang H, Qin H, Guo Z, Xue H, Hu J, et al. Changes in disposition of ezetimibe and its active metabolites induced by impaired hepatic function: the influence of enzyme and transporter activities. Pharmaceutics. 2022;14:2743.","journal-title":"Pharmaceutics"},{"key":"2219_CR14","doi-asserted-by":"publisher","first-page":"1414059","DOI":"10.3389\/fphar.2024.1414059","volume":"15","author":"E Gonz\u00e1lez-Iglesias","year":"2024","unstructured":"Gonz\u00e1lez-Iglesias E, Ochoa D, Navarres-G\u00f3mez M, Zubiaur P, Aldama M, de la Torre T, et al. Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics. Front Pharmacol. 2024;15:1414059.","journal-title":"Front Pharmacol"},{"key":"2219_CR15","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.2147\/DDDT.S550340","volume":"19","author":"SE Priani","year":"2025","unstructured":"Priani SE, Chaerunisaa AY, Wilar G, Sopyan I. Formulation strategies for ezetimibe and its combinations: advancing biopharmaceutical and therapeutic potential. Drug Des Devel Ther. 2025;19:8555\u201380.","journal-title":"Drug Des Devel Ther"},{"key":"2219_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/molecules26051485","volume":"26","author":"YO Agrawal","year":"2021","unstructured":"Agrawal YO, Mahajan UB, Agnihotri VV, Nilangekar MS, Mahajan HS, Sharma C, et al. Ezetimibe-loaded nanostructured lipid carrier based formulation ameliorates hyperlipidaemia in an experimental model of high fat diet. Molecules. 2021;26:1485.","journal-title":"Molecules"},{"key":"2219_CR17","first-page":"8103","volume":"9","author":"D Elkhayat","year":"2024","unstructured":"Elkhayat D, Abdelmalak NS, Amer R, Awad HH. Ezetimibe-loaded nanostructured lipid carrier for oral delivery: response surface methodology; in vitro characterization and assessing the antihyperlipidemic effect in rats. ACS Omega. 2024;9:8103\u201316.","journal-title":"ACS Omega"},{"key":"2219_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s44174-022-00041-0","volume":"1","author":"R Kesharwani","year":"2023","unstructured":"Kesharwani R, Jaiswal P, Patel DK, Yadav PK. Lipid-based drug delivery system (LBDDS): an emerging paradigm to enhance oral bioavailability of poorly soluble drugs. Biomed Mater Devices. 2023;1:648\u201363.","journal-title":"Biomed Mater Devices"},{"key":"2219_CR19","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/pharmaceutics13111817","volume":"13","author":"SLJ Tan","year":"2021","unstructured":"Tan SLJ, Billa N. Improved bioavailability of poorly soluble drugs through gastrointestinal muco-adhesion of lipid nanoparticles. Pharmaceutics. 2021;13:1817.","journal-title":"Pharmaceutics"},{"key":"2219_CR20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/pharmaceutics12121194","volume":"12","author":"AB Buya","year":"2020","unstructured":"Buya AB, Belouqui A, Memvanga PB, Pr\u00e9at V. Self-nano-emulsifying drug-delivery systems: from the development to the current applications and challenges in oral drug delivery. Pharmaceutics. 2020;12:1194.","journal-title":"Pharmaceutics"},{"key":"2219_CR21","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2174\/0113816128296705240327065131","volume":"30","author":"A Chauhan","year":"2024","unstructured":"Chauhan A, Kamal R, Mishra R, Shekho D, Awasthi A. A comprehensive guide to the development, evaluation, and future prospects of self-nanoemulsifying drug delivery systems for poorly water-soluble drugs. Curr Pharm Des. 2024;30:1211\u20136.","journal-title":"Curr Pharm Des"},{"key":"2219_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s13346-022-01193-8","volume":"13","author":"C Rathore","year":"2023","unstructured":"Rathore C, Hemrajani C, Sharma AK, Gupta PK, Jha NK, Aljabali AA, et al. Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies. Drug Deliv Transl Res. 2023;13:292\u2013307.","journal-title":"Drug Deliv Transl Res"},{"key":"2219_CR23","first-page":"6640103","volume":"2023","author":"P Preeti","year":"2023","unstructured":"Preeti P, Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Rani C, et al. Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs. Scientifica (Cairo). 2023;2023:6640103.","journal-title":"Scientifica (Cairo)"},{"key":"2219_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2147\/DDDT.S447496","volume":"18","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liang Y, Yuhong J, Xin P, Han JL, Du Y. Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Des Devel Ther. 2024;18:1469\u201395.","journal-title":"Drug Des Devel Ther"},{"key":"2219_CR25","first-page":"6147","volume":"10","author":"R Rashid","year":"2015","unstructured":"Rashid R, Kim DW, Yousaf AM, Mustapha O, Din FU, Park JH, et al. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Int J Nanomed. 2015;10:6147\u201359.","journal-title":"Int J Nanomed"},{"key":"2219_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12951-022-01539-x","volume":"20","author":"DA Subramanian","year":"2022","unstructured":"Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnol. 2022;20:362.","journal-title":"J Nanobiotechnol"},{"key":"2219_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/pharmaceutics17010063","volume":"17","author":"P Uttreja","year":"2025","unstructured":"Uttreja P, Karnik I, Youssef AA, Narala N, Elenkayati RM, Baisari S, et al. Self-emulsifying drug delivery systems (SEDDS): transition from liquid to solid\u2014a comprehensive review of formulation, characterization, applications, and future trends. Pharmaceutics. 2025;17:63.","journal-title":"Pharmaceutics"},{"key":"2219_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s40005-024-00707-5","volume":"55","author":"SG Jin","year":"2025","unstructured":"Jin SG, Cho JH, Choi HG. Integrative nanoparticulate strategies with SEDDS for controlled drug release: from lipid platforms to smart delivery systems. J Pharm Investig. 2025;55:497\u2013528.","journal-title":"J Pharm Investig"},{"key":"2219_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/pharmaceutics15041313","volume":"15","author":"N Desai","year":"2023","unstructured":"Desai N, Rana D, Salave S, Gupta R, Patel P, Karunakaran B, et al. Chitosan: a potential biopolymer in drug delivery and biomedical applications. Pharmaceutics. 2023;15:1313.","journal-title":"Pharmaceutics"},{"key":"2219_CR30","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3390\/pharmaceutics15092361","volume":"15","author":"T Sangnim","year":"2023","unstructured":"Sangnim T, Dheer D, Jangra N, Huanbutta K, Puri V, Sharma A. Chitosan in oral drug delivery formulations: a review. Pharmaceutics. 2023;15:2361.","journal-title":"Pharmaceutics"},{"key":"2219_CR31","doi-asserted-by":"publisher","first-page":"121926","DOI":"10.1016\/j.carbpol.2024.121926","volume":"333","author":"K Ahmad","year":"2024","unstructured":"Ahmad K, Zhang Y, Chen P, Yang X, Hou H. Chitosan interaction with stomach mucin layer to enhances gastric retention and mucoadhesive properties. Carbohydr Polym. 2024;333:121926.","journal-title":"Carbohydr Polym"},{"key":"2219_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/md20050335","volume":"20","author":"P Mura","year":"2022","unstructured":"Mura P, Maestrelli F, Cirri M, Mennini N. Multiple roles of chitosan in mucosal drug delivery: an updated review. Mar Drugs. 2022;20:335.","journal-title":"Mar Drugs"},{"key":"2219_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ijbiomac.2020.03.148","volume":"154","author":"X Lang","year":"2020","unstructured":"Lang X, Wang T, Sun M, Chen X, Liu Y. Advances and applications of chitosan-based nanomaterials as oral delivery carriers: a review. Int J Biol Macromol. 2020;154:433\u201345.","journal-title":"Int J Biol Macromol"},{"key":"2219_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13036-024-00403-w","volume":"18","author":"SC Guti\u00e9rrez-Ru\u00edz","year":"2024","unstructured":"Guti\u00e9rrez-Ru\u00edz SC, Cortes H, Gonz\u00e1lez-Torres M, Almarhoon ZM, S\u00f6nmez G\u00fcre E, Sharifi-Rad J, et al. Optimize the parameters for the synthesis by the ionic gelation technique, purification, and freeze-drying of chitosan-sodium tripolyphosphate nanoparticles for biomedical purposes. J Biol Eng. 2024;18:12.","journal-title":"J Biol Eng"},{"key":"2219_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/antiox11030479","volume":"11","author":"ES Kim","year":"2022","unstructured":"Kim ES, Baek Y, Yoo HJ, Lee JS, Lee HG. Chitosan-tripolyphosphate nanoparticles prepared by ionic gelation improve the antioxidant activities of astaxanthin in the in vitro and in vivo model. Antioxid (Basel). 2022;11:479.","journal-title":"Antioxid (Basel)"},{"key":"2219_CR36","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.3390\/ijms22179652","volume":"22","author":"V Miku\u0161ov\u00e1","year":"2021","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P. Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci. 2021;22:9652.","journal-title":"Int J Mol Sci"},{"key":"2219_CR37","doi-asserted-by":"publisher","first-page":"e14281","DOI":"10.1016\/j.heliyon.2023.e14281","volume":"9","author":"R Yousaf","year":"2023","unstructured":"Yousaf R, Khan MI, Akhtar MF, Madni A, Sohail MF, Saleem A, et al. Development and in-vitro evaluation of chitosan and glyceryl monostearate based matrix lipid polymer hybrid nanoparticles (LPHNPs) for oral delivery of itraconazole. Heliyon. 2023;9:e14281.","journal-title":"Heliyon"},{"key":"2219_CR38","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/pharmaceutics13081291","volume":"13","author":"D Sivadasan","year":"2021","unstructured":"Sivadasan D, Sultan MH, Madkhali O, Almoshari Y, Thangavel N. Polymeric lipid hybrid nanoparticles (PLNs) as emerging drug delivery platform\u2014a comprehensive review of their properties, preparation methods, and therapeutic applications. Pharmaceutics. 2021;13:1291.","journal-title":"Pharmaceutics"},{"key":"2219_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/jfb14090437","volume":"14","author":"S Jain","year":"2023","unstructured":"Jain S, Kumar M, Kumar P, Verma J, Rosenholm JM, Bansal KK, et al. Lipid\u2013polymer hybrid nanosystems: a rational fusion for advanced therapeutic delivery. J Funct Biomater. 2023;14:437.","journal-title":"J Funct Biomater"},{"key":"2219_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/polym16020290","volume":"16","author":"M Chountoulesi","year":"2024","unstructured":"Chountoulesi M, Pippa N, Forys A, Trzebicka B, Pispas S. Structure-based evaluation of hybrid lipid\u2013polymer nanoparticles: the role of the polymeric guest. Polym (Basel). 2024;16:290.","journal-title":"Polym (Basel)"},{"key":"2219_CR41","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.3390\/ijms24054289","volume":"24","author":"OR Guadarrama-Escobar","year":"2023","unstructured":"Guadarrama-Escobar OR, Serrano-Casta\u00f1eda P, Anguiano-Almaz\u00e1n E, V\u00e1zquez-Dur\u00e1n A, Pe\u00f1a-Ju\u00e1rez MC, Vera-Graziano R, et al. Chitosan nanoparticles as oral drug carriers. Int J Mol Sci. 2023;24:4289.","journal-title":"Int J Mol Sci"},{"key":"2219_CR42","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s12951-024-02930-6","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Mo Y, Sun Y, Li J, An Y, Feng N, et al. Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle\u2013cell interplay in mucosa based on physiochemical properties. J Nanobiotechnol. 2024;22:669.","journal-title":"J Nanobiotechnol"},{"key":"2219_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ijbiomac.2013.08.002","volume":"61","author":"D Sakloetsakun","year":"2013","unstructured":"Sakloetsakun D, D\u00fcnnhaupt S, Barthelmes J, Perera G, Bernkop-Schn\u00fcrch A. Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. Int J Biol Macromol. 2013;61:363\u201372. https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.08.002.","journal-title":"Int J Biol Macromol"},{"key":"2219_CR44","doi-asserted-by":"publisher","first-page":"101524","DOI":"10.1016\/j.jddst.2020.101524","volume":"56","author":"E Kontogiannidou","year":"2020","unstructured":"Kontogiannidou E, Meikopoulos T, Virgiliou C, Bouropoulos N, Gika H, Vizirianakis IS, et al. Towards the development of self-nano-emulsifying drug delivery systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: in vitro assessment and cytocompatibility studies. J Drug Deliv Sci Technol. 2020;56:101524. https:\/\/doi.org\/10.1016\/j.jddst.2020.101524.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2219_CR45","doi-asserted-by":"publisher","first-page":"105052","DOI":"10.1016\/j.chemphyslip.2021.105052","volume":"235","author":"S Saifullah","year":"2021","unstructured":"Saifullah S, Kanwal T, Ullah S, Kawish M, Habib SM, Ali I, et al. Design and development of lipid modified chitosan containing muco-adhesive self-emulsifying drug delivery systems for cefixime oral delivery. Chem Phys Lipids. 2021;235:105052. https:\/\/doi.org\/10.1016\/j.chemphyslip.2021.105052.","journal-title":"Chem Phys Lipids"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02219-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:06:28Z","timestamp":1789574788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02219-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":45,"alternative-id":["2219"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02219-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was approved by the Institutional Animal Care and Use Committee of Hanmi Pharmaceutical Co., Ltd. (approval no. KV24035, 2024).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":2,"name":"Ethics","label":"Animal Welfare Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}